Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ZEB1 induced‐upregulation of long noncoding RNA ZEB1‐AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA
Na Luo, Kejing Zhang, Xin Li, et al.
Journal of Cellular Biochemistry (2020) Vol. 121, Iss. 10, pp. 4176-4187
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Roles of miRNA and IncRNA in triple-negative breast cancer
Juan Xu, Kangjing Wu, Qiaojun Jia, et al.
Journal of Zhejiang University SCIENCE B (2020) Vol. 21, Iss. 9, pp. 673-689
Open Access | Times Cited: 99
RETRACTED ARTICLE: MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer
Jing Han, Hongbo Qu, Mingli Han, et al.
Oncogene (2020) Vol. 40, Iss. 4, pp. 833-847
Closed Access | Times Cited: 82
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 32
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
Krishan Kumar Thakur, Aviral Kumar, Kishore Banik, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 12, pp. 7938-7965
Closed Access | Times Cited: 50
Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process
Marina Melixetian, Pier Giuseppe Pelicci, Luisa Lanfrancone
Cells (2022) Vol. 11, Iss. 3, pp. 577-577
Open Access | Times Cited: 33
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments
Min Zhang, Fangxu Zhang, Jianfeng Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non–small cell lung cancer through stabilizing VEGFA by EIF4A3
Huizhen Yang, Wuchen Yang, Wanqing Dai, et al.
Cell Biology International (2020) Vol. 44, Iss. 8, pp. 1671-1680
Closed Access | Times Cited: 48
Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark
Shanshan Zhao, Xue Zhang, Shuo Chen, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 46
Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis
Feiyu Chen, Zhiyang Zhou, Kejing Zhang, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 36
Dualistic role of ZEB1 and ZEB2 in tumor progression
Sergey Parfenyev, Alexandra Daks, Oleg Shuvalov, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Advances in the study of antisense long‑stranded non‑coding RNAs in tumors (Review)
Yifan Shao, Yuwei Dong, Jing Zhou, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 3
Closed Access | Times Cited: 3
Exosomal Long Noncoding Rna AGAP2-AS1 Regulates Trastuzumab Resistance via Inducing Autophagy in Breast Cancer
Mingli Han, Hongbo Qu, Hui Cao, et al.
Research Square (Research Square) (2020)
Closed Access | Times Cited: 26
Epigenetic Mechanisms of LncRNAs Binding to Protein in Carcinogenesis
Tae-Jin Shin, Kang-Hoon Lee, Je‐Yoel Cho
Cancers (2020) Vol. 12, Iss. 10, pp. 2925-2925
Open Access | Times Cited: 25
The patterns of antisense long non-coding RNAs regulating corresponding sense genes in human cancers
Min Zhou, Xingjun Guo, Min Wang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 5, pp. 1499-1506
Open Access | Times Cited: 22
LncRNA SNHG8 Serves as an Oncogene in Breast Cancer Through miR-634/ZBTB20 Axis
Xianyun Xu, Qiongjun Xie, Mingfeng Xie, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 3017-3028
Open Access | Times Cited: 21
A review on the role of ZEB1-AS1 in human disorders
Soudeh Ghafouri‐Fard, Arian Askari, Kimia Behzad Moghadam, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154486-154486
Open Access | Times Cited: 9
Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
Dharambir Kashyap, Riya Sharma, Neelam Goel, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 8
Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells
Penn Muluhngwi, Carolyn M. Klinge
Cancers (2021) Vol. 13, Iss. 14, pp. 3530-3530
Open Access | Times Cited: 20
Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
Alina Catalina Palcau, R. Brandi, Nikolay Mehterov, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4181-4181
Open Access | Times Cited: 7
Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis
Qing Lü, Weili Chen, Ya-Jie Ji, et al.
Cancer Biotherapy and Radiopharmaceuticals (2021) Vol. 37, Iss. 8, pp. 673-683
Closed Access | Times Cited: 16
ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells
Eun Ju Kim, Jeong Seon Kim, Sieun Lee, et al.
Cancer Letters (2022) Vol. 533, pp. 215601-215601
Closed Access | Times Cited: 11
The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells
Qidi Huang, Shurong Zheng, Huayan Gu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 2
miR-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients
Yuwei Dong, Fuxia Li, Junjun Wang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 10, pp. 3067-3076
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top